Current ISSUE


2021; volume 31, Issue 1
more issues

Editorial

Editorial
Olaguibel J.M.
[summary] [PDF full-Text]

Review

Treatment of Hereditary Angioedema
Caballero T
[summary] [PDF full-Text] Continual Medical Education ( credits)

Functional Examination of the Upper and Lower Airways in Asthma and Respiratory Allergic Diseases: Considerations in the Post–SARS-CoV-2 Era
Olaguibel JM, Alobid I, Alvarez Puebla M, Crespo-Lessmann A, Domínguez Ortega J, García-Rio F, Izquierdo-Domínguez A, Mullol J, Plaza V, Quirce S, Rojas-Lechuga MJ, Valvere-Monge M, Sastre J
[summary] [PDF full-Text]

Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement
Delgado J, Dávila IJ, Domínguez-Ortega J, Severe Asthma Group (SEAIC)
[summary] [PDF full-Text] [Supplemental Materials]

Original Articles

Farm Environment During Pregnancy and Childhood and Polysensitization at the Age of 31: Prospective Birth Cohort Study in Finland
Karvonen AM, Lampi J, Keski-Nisula L, Auvinen J, Toppila-Salmi S, Järvelin M, Pekkanen J
[summary] [PDF full-Text]

A Comprehensive Prospective Study of the Costs Associated With Evaluation of ß-Lactam Allergy
Sobrino-García M, Muñoz-Bellido FJ, Moreno E, Macías E, Gracia-Bara MT, Laffond E, Lázaro-Sastre M, Martín-García C, de Arriba-Méndez S, Campanón-Toro MV, Gallardo-Higueras A, Dávila I
[summary] [PDF full-Text]

Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records
Plaza V, Giner J, Curto E, Alonso-Ortiz MB, Orue MI, Vega JM, Cosío BG, Investigators of the RE-TAI study
[summary] [PDF full-Text]

Practitioner’s Corner

Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab
Szekely S, Vaccari D, Salmaso R, Belloni-Fortina A, Alaibac M
[summary] [PDF full-Text]

IgE-Mediated Hypersensitivity to Lysine Clonixinate
Villalón García AL, Pérez Pimiento A, López San Martín MG, Iglesias Cadarso A
[summary] [PDF full-Text]

Early-Onset Inflammatory Bowel Disease Caused by Mutations in the X-Linked Gene IL2RG
Ogawa A, Watanabe T, Natsume T, Okura E, Saito S, Kato S, Nakayama Y, Furukawa S, Yamaguchi T, Kosho T, Uehara T, Kobayashi N, Agematsu K, Nakazawa Y, Shigemura T
[summary] [PDF full-Text]

Anaphylaxis Due to Senna (Cassia angustifolia)
Irazábal B, Sánchez de Vicente J, Galán C, Segurola A, Seras Y, García-Lirio E, Martínez Antón MD, Bartolomé B, Jáuregui I
[summary] [PDF full-Text]

Approach to Occupational Contact Dermatitis in an Industrialized Region of Spain
Carvallo A, Quan P, Goikoetxea MJ, Ferrer M, Penella J, Morales-Palacios MP, Gastaminza G, D’Amelio CM
[summary] [PDF full-Text]

Serum Concentrations of Interleukin 6 in the General Adult Population: Possible Implications for Anti–IL-6 Therapy in SARS-Cov-2 Infection and IL-6–Related Diseases
Alende-Castro V, Alonso-Sampedro M, Gude F, Gonzalez-Quintela A
[summary] [PDF full-Text]

Pertinence of Telehealth in a Rush Conversion to Virtual Allergy Practice During the COVID-19 Outbreak
González-Pérez R, Sánchez-Machín I, Poza-Guedes P, Matheu V, Álava-Cruz C, Mederos Luís E
[summary] [PDF full-Text]

Shortened Up-Dosing With 7 Injections of Subcutaneous Allergy Immunotherapy (Alutard SQ) Is Safe and Well Tolerated
Horn A, Fernández-Rivas M, Wolf H, Ghaussy N, Møller Kruse T, Koutromanou K, Wüstenberg E
[summary] [PDF full-Text]

An Unexpected Effect of Maraviroc Could Make It a Future Treatment for Sarcoidosis
Goehringer F, Tiotiu A, Schvoerer E, Jaussaud R, Hoen B
[summary] [PDF full-Text]

Letters to the Editor

The Rediscovery of Hydroxychloroquine in Allergic Diseases in the COVID-19 Era
Bonzano L, Cassone G, Tarallo L, Pellacani G
[summary] [PDF full-Text]

Benralizumab in Real Life
Miralles López JC, Escudero Pastor AI, Carbonell Martínez A, Navarro Garrido C, Bonilla Pacheco Y, Petrik Petrik Y
[summary] [PDF full-Text]

The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy
Ortega Rodríguez NR, Audícana Berasategui MT, de la Hoz Caballer B, Valero Santiago A
[summary] [PDF full-Text]

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines
Caballero ML, Quirce S
[summary] [PDF full-Text]

Reviewers

Reviewers 2020

[summary] [PDF full-Text]